Multiple endocrine neoplasia type 1: new clinical and basic findings

Area of Science:

• Endocrinology
• Genetics
• Oncology

Background:

• Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant disease.
• MEN1 is characterized by tumors of the parathyroid, enteropancreatic neuroendocrine, anterior pituitary, and foregut carcinoid.
• The MEN1 gene, encoding the menin protein, is implicated in various endocrine and non-endocrine tumors.

Purpose of the Study:

• To provide an overview of recent scientific advances in MEN1 research.
• To highlight newly recognized clinical features and their genetic basis.
• To discuss updated recommendations for mutation testing and tumor screening.

Main Methods:

• Review of recent scientific literature on MEN1.
• Analysis of genetic findings related to MEN1.
• Evaluation of clinical features and tumor characteristics.

Main Results:

• Genetic analysis has refined the understanding of MEN1 clinical features.
• Insights into the function of the menin protein have been gained.
• Improved recommendations for MEN1 mutation testing and tumor screening are available.

Conclusions:

• Recent advances have significantly increased our understanding of the MEN1 syndrome.
• Genetic analysis and functional studies of menin are crucial for managing MEN1.
• Updated screening and testing protocols enhance early detection and patient care.